Last update 16 Jul 2024

XENON XE 129 hyperpolarized

Overview

Basic Info

Drug Type
Contrast agent, Chemical drugs
Synonyms
129Xe, Hyperpolarized 129-Xenon, hyperpolarized xenon Xe 129
+ [1]
Target-
Mechanism
Magnetic resonance imaging enhancers
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaXe
InChIKeyFHNFHKCVQCLJFQ-YPZZEJLDSA-N
CAS Registry13965-99-6

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Contrast agents
US
23 Dec 2022
Lung Diseases
US
23 Dec 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pulmonary Arterial HypertensionPhase 2
US
27 Oct 2023
Pulmonary Arterial HypertensionPhase 2
US
27 Oct 2023
Chronic thromboembolic pulmonary hypertensionPhase 2
US
15 Sep 2023
Lung Diseases, InterstitialPhase 2
US
15 Sep 2023
Pulmonary EmbolismPhase 2
US
15 Sep 2023
Idiopathic Pulmonary FibrosisPhase 2
US
-19 Jul 2022
Progressive pulmonary fibrosisPhase 2
US
-19 Jul 2022
Bronchopulmonary DysplasiaPhase 1
US
01 Aug 2023
Pulmonary Disease, Chronic ObstructivePhase 1-27 Jun 2022
Non-Small Cell Lung CancerPhase 1
US
17 Mar 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
38
129Xe MRI
dpyvajwhgh(sacltjczys) = qzvijhkjbt ufunqzsnqg (fekeubhvss, uvmhqviwpe - otzijecdbv)
-
28 Jun 2022
Not Applicable
33
Hyperpolarised 129-xenon
idljkzndxh(lrjqearsqi) = nbgovdwjno fprjytjftb (hvvoktvmxv )
-
28 Sep 2019
Hyperpolarised 129-xenon
idljkzndxh(lrjqearsqi) = mqrbomypax fprjytjftb (hvvoktvmxv )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free